Previous Article | Next Article 
Infection and Immunity, March 2001, p. 1630-1634, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1630-1634.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Marrow-Derived CD40-Positive Cells Are Required for
Mice To Clear Cryptosporidium parvum Infection
Anthony R.
Hayward,*
Mary
Cosyns,
Michelle
Jones, and
Esther M.
Ponnuraj
Departments of Pediatrics and Immunology and
the Barbara Davis Childhood Diabetes Center, University of Colorado
School of Medicine, Denver, Colorado
Received 5 September 2000/Returned for modification 11 October
2000/Accepted 12 December 2000
 |
ABSTRACT |
To clear a Cryptosporidium parvum infection, mice need
CD4+ T cells, major histocompatibility complex class II,
and an intact CD40-CD154 signaling pathway. CD40 is constitutively
expressed on marrow-derived cells such as dendritic cells and B
lymphocytes and is induced by gamma interferon (IFN-
) on most
somatic cells. To determine whether the CD40 needed to clear a C. parvum infection has to be on marrow-derived mononuclear cells or
on the epithelial cells that normally harbor the parasite, we
transplanted CD40
/
mice with CD40+/
bone
marrow and then infected them with C. parvum. These
chimeras cleared the C. parvum infection, while
CD40+/
controls transplanted with CD40
/
marrow cells remained infected. CD40 expression on
marrow-derived cells therefore suffices for a C. parvum infection to be cleared, while CD40 expression on
intestinal epithelial cells is not sufficient. There was no difference
between the acquisition of CD69 and CD154 by mesenteric lymph node T
cells of C. parvum-infected animals with intact or
disrupted CD40-CD154 pathways. CD4 T cells entered the intestinal
laminae propriae of C. parvum-infected animals whether
or not the CD40 genes of these recipients were intact. These results
suggest that, for a C. parvum infection to be cleared, CD40 is not necessary for T-cell activation but may instead contribute to an effector pathway of marrow-derived cells.
 |
INTRODUCTION |
Cryptosporidium parvum is
an apicomplexan organism that infects intestinal epithelial cells and
causes transient diarrhea in healthy individuals (11).
C. parvum infections cause more severe problems,
ranging from prolonged diarrhea to sclerosing cholangitis, in subjects
with AIDS or X-linked immunodeficiency with hyper-immunoglobulin M
(IgM) (6, 17). Experimental models in mice show that
CD4+ T cells (26), major histocompatibility
complex class II (MHC-II) (1), and an intact CD40-CD154
pathway (10) are all required for C. parvum to be cleared from the gut and biliary tree. Gamma interferon (IFN-
) and interleukin-12 (IL-12) contribute to
recovery from C. parvum infection (32,
33), although the ability of many IFN-
knockout mice to
recover from C. parvum (36, 30) indicates
that this cytokine is not invariably necessary for the parasite to be cleared.
The nature of the interaction between the CD4+ T cell and
an MHC-II-bearing cell that is required for the clearing of
C. parvum from the gut is not understood.
Cryptosporidial sporozoites invaginate into epithelial cells of the
intestinal epithelium, but they remain separated from the cell
cytoplasm by an intact cellular cytoplasmic membrane (24).
Conventional pathways for antigen, and particularly class I antigen,
presentation (15) may therefore not hold for the handling
of C. parvum antigens. Intestinal epithelial cells can
express MHC-II antigens and are thought capable of one or more pathways
of antigen presentation (18). Populations of
intraepithelial lymphocytes and lamina propria lymphocytes may have
access to gut-derived antigens displayed in the context of class II
antigens on the basolateral extensions of epithelial cells. It is
therefore conceivable that T-cell responses that mediate immunity to
C. parvum could occur without the participation of a
marrow-derived antigen-presenting cell (APC) (19).
It was previously shown that CD4 T cells expressing a transgene for an
ovalbumin-specific antigen receptor sufficed to clear C. parvum infection from SCID mice, provided that the transgenic T
cells became activated and were able to express CD154
(23). This result suggested that the clearance of
C. parvum required an interaction between CD154
(presumably expressed on an activated T cell) and CD40. A role for
CD154-CD40 interactions has been described in immune responses to other
intracellular parasites, albeit in the context of antigen-specific
responses (25, 31, 35). These CD40-CD154 interactions may
contribute a direct afferent signal to the T cell, or they may trigger
the CD40-positive cell (for example, a B cell, dendritic cell, or
macrophage) to make a mediator such as IL-12 (22, 14) or
nitric oxide (29). Expression of CD40, however, can be
induced on a wide range of cells by IFN-
(12). If
C. parvum-infected epithelial cells were to express
CD40, then CD154 on T cells might act directly upon them to trigger
their apoptosis (20) or perhaps affect their handling of
an intracellular pathogen. For example, a soluble CD154 trimer sufficed
to trigger the apoptosis of C. parvum-infected cells in
vitro (17).
To determine whether the cellular target for CD154 binding that is
required for C. parvum to be cleared is a
marrow-derived cell or an epithelial cell (the cell type infected by
C. parvum), we created chimeras by transplanting
CD40+/
marrow into CD40
/
mice. The
results presented here show that expression of CD40 on a marrow-derived
cell is sufficient for C. parvum infection to be
cleared from a mouse that cannot express CD40 on intestinal epithelial cells. In contrast, CD40+/
mice transplanted
with CD40
/
marrow were unable to clear C. parvum. The induction of CD69 and CD154 on CD4 cells from the
mesenteric lymph nodes of animals with disrupted and intact CD40-CD154
pathways argues against an essential role for CD40 in the activation
phase of the T-cell response to C. parvum.
 |
MATERIALS AND METHODS |
Mice.
C57BL/6 wild-type, B6 RAG
/
and
IgM(µ) heavy-chain knockout (JR2288) mice were purchased from Jackson
Laboratory (details of these mice are given at www.jaxmice.jax.org).
The sources, breeding, genotyping, and care of the C57BL/6 SCID,
C57BL/6 CD154
/
, and C57BL/6 CD40
/
(knockout) mice are described in references 10 and
23. Animal conditions and experimentation were approved by
the Institutional Animal Care and Use Committee of the University of
Colorado School of Medicine.
Marrow transplant chimeras and adoptive transfer.
Mice were
irradiated with 950 rads from a cesium source at 250 rads/min. Within 1 h they were injected with 107 spleen and marrow cells from
donors of the same sex. These cells were prepared by flushing the cells
from the marrow of the femurs and humeri of euthanized donors with
Hanks' balanced salt solution (HBSS). These cells were counted and
mixed with an equal number of spleen cells from the same donors, also
suspended in HBSS. Clumps were removed by filtering through nylon mesh,
and the cell suspension was adjusted to 108/ml. One hundred
microliters (107 cells) was injected where indicated into
the peritoneal cavity of the irradiated mice. Recipients were
maintained on trimethoprim-sulfamethoxazole (Septra) for 2 weeks after
transplantation. They were allowed to recover for 6 weeks before being
used for experimentation in the expectation that this would allow
sufficient time for reconstitution by donor-derived APCs.
Infection and testing for C. parvum.
Experimental groups of mice were always derived from more than one
litter and included both males and females. Animals were transferred to
a biohazard facility for infection with C. parvum strain GCH1, obtained from McKesson Bioservices (catalog no. 1372) through the AIDS Research and Reference Reagent Program of the National
Institute of Allergy and Infectious Diseases, National Institutes of
Health (Bethesda, Md.), as previously described (23). Over
50% of these oocysts excyst after being washed in bleach and incubated
for 4 h at 37°C. Animals were infected by gavage once with
106 oocysts in 0.1 ml of HBSS. This number of oocysts is
several orders of magnitude greater than the mouse 50% infective dose for C. parvum. Mouse feces were collected weekly and
stored at
20°C until the infection status was determined by fecal
C. parvum antigen using a commercial C. parvum antigen enzyme-linked immunosorbent assay (ELISA) kit (LMD,
catalog no. CP-35; Alexon, Ramsey, Minn.). Feces were resuspended in
the homogenization buffer overnight at 4°C before testing according
to the manufacturer's instructions. Positive and negative controls
were included with each ELISA run. Animals were euthanized by
CO2 inhalation (a) when they lost 15% of body weight or
(b) at 6 to 13 weeks after infection or adoptive transfer of T
cells. Tissues obtained at necropsy for routine histology were fixed in
10% buffered formalin and embedded in paraffin for sectioning and
hematoxylin and eosin staining. Tissues to be used for detection of 5- (and 6-) carboxyfluorescein, succinimidyl ester (CFSE)-labeled cells
were snap-frozen and sectioned on a cryostat.
Preparation and transfer of mesenteric lymph node
suspensions.
For certain experiments, mesenteric lymph nodes were
teased in HBSS and adjusted to 107/ml. These cells were
fluorescence labeled by CFSE (catalog no. C-1311; Molecular Probes,
Portland, Oreg.) as previously described (23) and
resuspended at 108/ml in HBSS. Ten million cells were
injected intraperitoneally into wild-type and knockout recipients as
indicated below. The division of these cells was assessed by
fluorescence-activated cell sorter analysis, and their appearance in
the gut was detected by fluorescence microscopy of frozen sections.
These were viewed on a Leitz microscope with incident UV light and
transmitted phase-contrast optics. Images were captured with a Spot
camera (model 1.3.0; Diagnostic Instruments, Sterling Heights, Mich.)
and processed with Adobe Photoshop software.
Fluorescence staining.
For fluorescence-activated cell
sorter analysis, 106 mesenteric lymph node or spleen cells
were spun down and resuspended in 5 to 10 µl of
fluorochrome-conjugated antibodies to B220, CD4, CD154, or CD69
(Caltag, Burlingame, Calif., or Pharmingen, San Diego, Calif.) and
incubated on ice for 30 min. An aliquot of cells was stained with
phycroerythrin and fluorescein isothiocyanate controls in parallel. The
cells were washed twice and fixed in 1% paraformaldehyde before being
viewed on an EPICS Elite cytofluorograph.
 |
RESULTS |
CD40 on a marrow-derived cell suffices for C. parvum to be cleared by C57BL/6 mice.
C57BL/6
CD40
/
mice, irradiated with 950 rads and reconstituted
with 107 CD40+/
donor cells, were rested for
6 weeks to allow for the repopulation of APCs with donor-derived
CD40+/
cells. Following infection by mouth with
106 C. parvum oocysts, these transplant
chimeras cleared the infection as judged by C. parvum
ELISAs (Fig. 1). The B220+
cells in blood and spleen samples obtained at necropsy from these animals stained for CD40 by two-color cytometry. Histology of necropsy sections of ileum also confirmed that the C. parvum infection had been cleared. CD40+/
animals
transplanted with CD40
/
bone marrow remained
infected by C. parvum for >8 weeks as shown by ELISA
(Fig. 1), and this was confirmed by histology of the terminal ileum
(not shown). B cells from these CD40+/
animals
reconstituted by CD40
/
marrow were negative for cell
surface CD40 (not shown). Positive-control transplant chimeras
comprising CD40+/
mice reconstituted with wild-type
marrow cleared the C. parvum infection (not shown),
while negative controls (CD40
/
mice reconstituted with
RAG knockout or CD40
/
marrow cells) remained infected
for >8 weeks (Table 1).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
C. parvum ELISA results (mean + 1 SD) for CD40 / C57BL/6 mice infected with
106 C. parvum oocysts. ,
CD40 / mice, unmanipulated; , CD40 /
mice transplanted with C57BL/6+/ bone marrow; ,
CD40 / mice transplanted with CD40 /
marrow; , CD40+/ mice transplanted with
CD40 / marrow. OD, optical density.
|
|
To exclude a role for antibody in the clearing of
C. parvum infection by the CD40
/
recipients of
CD40
+ marrow cells in the above experiment, we
repeated the experiment
using IgM (µ) chain knockout (B-cell
deficient) bone marrow donors.
Eight recipients of µ
/
marrow cells were infected with
C. parvum 6 weeks after
reconstitution,
and all cleared their
C. parvum
infection in the ensuing 6 weeks
(Table
1).
T-cell activation in CD40
/
mice infected with
C. parvum.
CD 40 transduces important signals
into APC that stimulate the expression of B7 and MHC and the secretion
of IL-12. These CD40-mediated functions are thought to increase the
ability of an APC to stimulate a T cell. To determine whether
CD40
/
mice would be unable to activate T cells in their
mesenteric lymph nodes (and so fail to clear a C. parvum infection), we examined CD4 cells from infected and
uninfected mice for expression of the early activation marker, CD69,
and for CD154. A single time point was required to permit comparisons
between groups, and because wild-type animals clear the infection
promptly, 6 days after infection was the time point selected. This
approximates the period of the 7 to 9 days after infection used in the
study with calves reported by Pasquali and coworkers (27).
Our results (Table 2) show in each case a
greater percentage of activated CD69+ cells in the infected
animals than in uninfected controls. Since there were no overlaps
between the infected and uninfected mice within groups, these
differences are significant by the Fisher exact test (P < 0.05). The percentages of CD4+ cells that expressed
CD69+ approximately doubled in the wild-type,
CD154
/
, or CD40
/
mice that were
infected with C. parvum, compared with the uninfected controls. Expression levels of CD154 were similar in C. parvum-infected wild-type and CD40
/
mice. To
determine whether the activation that occurred was followed by cell
division, spleen and mesenteric lymph node cells from wild-type C57BL/6
mice were CFSE labeled and injected into control and C. parvum-infected CD40
/
and wild-type mice. Six days
later, the recipients' mesenteric lymph nodes were recovered and
examined for CFSE fluorescence. Cell division was detected only in the
infected recipients (Fig. 2 illustrates
cell division by CD4 cells in a C. parvum-infected but
not an uninfected CD40
/
recipient). The mean + 1 standard deviation (SD) percentage of CD4 cells that divided
in the CD40
/
mice was 48% + 8%, and in the
C. parvum-infected wild-type recipients it was 38% + 12%. This difference does not reach statistical significance.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 2.
Green CFSE fluorescence of CD4 cells from mesenteric
lymph nodes of CD40 / mice 6 days after injection
of 107 CFSE-labeled spleen cells from wild-type
donors. (a) Uninfected recipient; (b) C. parvum-infected recipient. The appearance of additional
populations of cells with reduced green fluorescence in the region
labeled C of the infected animal is indicative of cell division. This
result is representative of five animals studied.
|
|
It was previously shown that T cells enter the laminae propriae of
C. parvum-infected SCID mice prior to clearing of the
infection
(
23). To determine whether CD40 was required for
T cells to
reach the lamina propria, we examined the guts of the
CD40
/
and wild-type
C. parvum-infected
recipients of the CFSE-labeled
cells described above. Donor-derived
cells identified through
CFSE fluorescence were found in 24% (SD, 7%)
of high-power fields
of laminae propriae from the guts of all five
CD40
/
C. parvum-infected animals tested
(an example is shown in Fig.
3). CFSE-labeled cells were found in 18% + 7% of high-power fields
of laminae propriae from the guts
of
C. parvum-infected wild-type
animals. The difference
between CD40
/
and wild-type animals is not
statistically significant. CFSE-labeled
cells were not detected in the
laminae propriae of CD40
/
animals that had not been
infected by
C. parvum (not shown).

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 3.
(a) CFSE-labeled cells in the intestine of a
C. parvum-infected CD40 / mouse 6 days
after injection of 107 CFSE-labeled wild-type spleen cells.
Magnification, ×400. Higher-power (magnification, ×1,000)
phase-contrast (b) and green fluorescence (c) views of ileum show that
labeled cells lie adjacent to the base of a crypt (arrow). Comparable
results were obtained with five more animals.
|
|
 |
DISCUSSION |
That T cells are necessary for a C. parvum
infection to be cleared is well established (26) and is
perhaps to be expected for an organism that principally resides in a
parasitophorous vacuole in an epithelial cell. This location is likely
to protect the intracellular sporozoite from antibody, but the
C. parvum sporozoites do not penetrate the cell wall to
enter the cytoplasm of the infected cell. Residence within a
parasitophorous vacuole is therefore likely to prevent sporozoite
antigens from entering a class I processing pathway. Certainly CD8 T
cells and MHC-I antigens do not seem to be required for cryptosporidia
to be cleared (1, 28). Even the CD4 T-cell response that
can clear a C. parvum infection is unusual in that the
specificity of the T-cell receptor seems less important than the
activation of the T cells and their utilization of an intact CD154-CD40
signaling pathway (23). CD40 ligation can lead to
apoptosis of fibroblasts (20) and, in vitro, of
C. parvum-infected cells (17, 30),
so the direct triggering of apoptosis in CD40+ infected
cells by CD154 expressed on activated T cells was considered a
potential mechanism that could account for the contribution of CD40 to
C. parvum immunity. The results presented here clearly refute this interpretation because CD40 was not required on the surface
of the infected intestinal epithelial cells for a C. parvum infection to be cleared. Instead, C. parvum
infections were cleared only when CD40 was present on a
marrow-derived cell. The marrow-derived populations that normally
express CD40 are B lymphocytes and cells of the dendritic and
mononuclear phagocyte series. Since CD40
/
recipients of
B-cell-deficient marrow were able to clear C. parvum infections, it appears that the required CD40+ population
is a member of the dendritic and mononuclear phagocyte series.
An implication from our finding that marrow-derived
CD40+ cells are required for a C. parvum infection to be cleared is that antigen presentation to T
cells through intestinal epithelial cells alone (19) is
insufficient for immunity. This conclusion is consistent with the
recent report from Blanas and colleagues (5) showing that
a marrow-derived MHC-II- positive cell is necessary for
ovalbumin-specific CD4 cells to proliferate in the mesenteric lymph
nodes of mice fed ovalbumin.
Immune responses to other intracellular pathogens (particularly
Leishmania, Toxoplasma, and Pneumocystis) have
emphasized the role of CD40 in stimulating APCs (most probably
dendritic cells) to make IL-12 (9). The production of
IL-12 is relevant because it is known to bias T cells towards a
IFN-
-secreting (or Th1) immune response. In the response to
Leishmania infection, IL-12 production by parasitized
dendritic cells depends on a CD40 transduced signal (25).
Since IL-12 is known to contribute to immunity to C. parvum (33), the principal contribution of CD40 ligation to the immune response to C. parvum might be
to ensure T-cell activation and subsequent IFN-
production.
Experiments in transplant systems show that dendritic cells deficient
in CD40 tend to make more of the down-regulatory cytokine IL-10
(13). Despite the relationship of CD40 to IL-12
production, our experimental results clearly show that CD4+
T cells in the mesenteric lymph nodes of CD40
/
C. parvum-infected mice activate at least to the
extent of CD69 expression. About a third of the mesenteric
lymph node CD4+ cells from C. parvum-infected animals also expressed CD154, whether these cells
came from CD40-positive or -knockout mice. Studies with CFSE-labeled
cells go further in showing that CD4 T cells divide in
CD40
/
adoptive hosts when these are C. parvum infected. This result is consistent with the recent report
of Howland et al. that CD4 T cells expressing the DO11.10 receptor for
ovalbumin, but with disrupted CD154, divide when stimulated by
ovalbumin
even though this response is not as well sustained as
that by cells with intact CD154 (21). These results, and
our own using CFSE labeling, are important because they suggest that
the absence of a potential afferent signal through CD154
(7) does not limit T-cell responses in
CD40
/
mice. Even IFN-
production in response to
intracellular pathogens can proceed when CD40-CD154 signaling is
blocked (34), provided that the B7-CD28 pathway is intact.
A recent report draws attention to TRANCE-TRANCE R signaling as a major
pathway in the production of IFN-
by activated T cells
(2). Taken together, these data argue against the view
that the principal role for CD40 in the response to C. parvum is for T-cell activation and subsequent IFN-
production.
While the findings reported here do not define the contribution that
CD40 makes to immunity to C. parvum, they do narrow the range of possibilities. The finding that educated CD40
/
T cells could not eliminate C. parvum from
CD40
/
knockout mice suggests that CD40 acts to mediate
an effector function that is not subserved by T cells and epithelial
cells alone. Studies with other apicomplexans, such as
Toxoplasma sp., implicate nitric oxide as an essential
mediator of immunity, and nitric oxide production by mononuclear
phagocytes is known to be stimulated through CD40. Even though nitric
oxide would be a plausible candidate for the essential
CD40-ligation-dependent mediator in C. parvum
clearance, we show elsewhere that inducible nitric oxide synthetase and
Fas/Fas ligand expression are not required to clear a C. parvum infection (16). Dendritic cells in the
intestinal lamina propria are CD40+, and both their
survival (8) and function (3) are affected by
CD40 signaling. Mononuclear phagocytes of the dendritic cell and
macrophage series have an important effector function against other
intracellular pathogens, and in the human lamina propria, they are
responsible for scavenging apoptotic epithelial cells (4).
Our present data argue for a further study of their interactions with
C. parvum-infected epithelial cells.
 |
ACKNOWLEDGMENTS |
We thank Gordon Macpherson, Ronald Gill, and Charles Dinarello
for helpful discussions.
This research was supported by grants from the March of Dimes
(6-FY99-427) and from the National Institutes of Health (AI40870).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: B 140, UCHSC, Denver, CO 80262. Phone: (303) 315-7462. Fax: (303)
315-4892. E-mail: anthony.hayward{at}uchsc.edu.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Aguirre, S. A.,
P. H. Mason, and L. E. Perryman.
1994.
Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection.
Infect. Immun.
62:697-699[Abstract/Free Full Text].
|
| 2.
|
Bachmann, M. F.,
B. R. Wong,
R. Josien,
R. M. Steinman,
A. Oxenius, and Y. Choi.
1999.
TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation.
J. Exp. Med.
189:1025-1031[Abstract/Free Full Text].
|
| 3.
|
Banchereau, J.,
F. Briere,
C. Caux,
J. Davoust,
S. Lebecque,
Y. J. Liu,
B. Pulendran, and K. Palucka.
2000.
Immunobiology of dendritic cells.
Annu. Rev. Immunol.
18:767-811[CrossRef][Medline].
|
| 4.
|
Barkla, D. H., and P. R. Gibson.
1999.
The fate of epithelial cells in the human large intestine.
Pathology
31:230-238[CrossRef][Medline].
|
| 5.
|
Blanas, E.,
G. M. Davey,
F. R. Carbone, and W. R. Heath.
2000.
A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells.
J. Immunol.
164:2890-2896[Abstract/Free Full Text].
|
| 6.
|
Blanshard, C.,
A. M. Jackson,
D. C. Shanson,
N. Francis, and B. G. Gazzard.
1992.
Cryptosporidiosis in HIV-seropositive patients.
Q. J. Med.
85:813-823[Abstract/Free Full Text].
|
| 7.
|
Brenner, B.,
U. Koppenhoeffer,
A. Lepple-Wienhaues,
H. Grassme,
C. Muller,
C.-P. Speer,
F. Lang, and E. Gulbins.
1997.
The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation.
Biochem. Biophys. Res. Commun.
239:11-17[CrossRef][Medline].
|
| 8.
|
Caux, C.,
B. Vanbervliet,
C. Massactier,
M. Azuma,
K. Okumura,
L. Lanier, and J. Bancherau.
1994.
Activation of human dendritic cells through CD40 crosslinking.
J. Exp. Med.
180:1263-1272[Abstract/Free Full Text].
|
| 9.
|
Cella, M.,
D. Scheidegger,
K. Palmer-Lehmann,
P. Lane,
A. Lanzavecchia, and G. Alber.
1996.
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.
J. Exp. Med.
184:747-752[Abstract/Free Full Text].
|
| 10.
|
Cosyns, M.,
S. Tsirkin,
M. Jones,
R. Flavell,
H. Kikutani, and A. R. Hayward.
1998.
Requirement for CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice.
Infect. Immun.
66:603-607[Abstract/Free Full Text].
|
| 11.
|
DuPont, H. L.,
C. L. Chappell,
C. R. Sterling,
P. C. Okhuysen,
J. B. Rose, and W. Jakubowski.
1995.
The infectivity of Cryptosporidium parvum in healthy volunteers.
N. Engl. J. Med.
332:855-859[Abstract/Free Full Text].
|
| 12.
|
Fries, K. M.,
G. D. Sempowski,
A. A. Gaspari,
T. Blieden,
R. J. Looney, and R. P. Phipps.
1995.
CD40 expression by human fibroblasts.
Clin. Immunol. Immunopathol.
77:42-51[CrossRef][Medline].
|
| 13.
|
Gao, J.-X.,
J. Madrenas,
W. Zeng,
M. J. Cameron,
Z. Zhang,
J.-J. Wang,
R. Zhong, and D. Grant.
1999.
CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T cell hyporesponsiveness in vitro and prevent acute allograft rejection.
Immunology
98:159-170[CrossRef][Medline].
|
| 14.
|
Grewal, I. S.,
J. Xu, and R. A. Flavell.
1995.
Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand.
Nature
378:617-620[CrossRef][Medline].
|
| 15.
|
Hammerling, G. J.,
A. B. Vogt, and H. Kropshofer.
1999.
Antigen processing and presentation towards the millennium.
Immunol. Rev.
172:5-9[CrossRef][Medline].
|
| 16.
|
Hayward, A. R.,
K. Chmura, and M. Cosyns.
2000.
Interferon- required for innate immunity to Cryptosporidium parvum in mice.
J. Infect. Dis.
182:1001-1004[CrossRef][Medline].
|
| 17.
|
Hayward, A. R.,
L. Levy,
F. Facchetti,
L. Notarangelo,
H. D. Ochs,
A. Etzioni, and A. Weinberg.
1995.
Cholangiopathy and tumors of the pancreas, liver and biliary tree in boys with X-linked immunodeficiency with hyper-IgM (XHIM).
J. Immunol.
158:977-983[Abstract].
|
| 18.
|
Hershberg, R. M., and L. F. Mayer.
2000.
Antigen processing and presentation by intestinal epithelial cells polarity and complexity.
Immunol. Today
21:123-128[CrossRef][Medline].
|
| 19.
|
Hershberg, R. M.,
P. E. Framson,
D. H. Cho,
L. Y. Lee,
S. Kovats,
J. Beitz,
J. S. Blum, and G. T. Nepom.
1997.
Intestinal epithelial cells utilize two distinct pathways for HLA class II antigen processing.
J. Clin. Investig.
100:204-215[Medline].
|
| 20.
|
Hess, S., and H. Engelmann.
1996.
A novel function of CD40: induction of cell death in transformed cells.
J. Exp. Med.
183:159-167[Abstract/Free Full Text].
|
| 21.
|
Howland, K. C.,
L. J. Ausubel,
C. A. London, and A. K. Abbas.
2000.
The roles of CD28 and CD40 ligand in T cell activation and tolerance.
J. Immunol.
164:4465-4470[Abstract/Free Full Text].
|
| 22.
|
Koch, F.,
U. Stanzl,
P. Jennewein,
K. Janke,
C. Heufler,
E. Kampgen,
N. Romani, and G. Schuler.
1996.
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10.
J. Exp. Med.
184:741-746[Abstract/Free Full Text].
|
| 23.
|
Lukin, K.,
M. Cosyns,
T. Mitchell,
M. Saffry, and A. Hayward.
2000.
Eradication of Cryptosporidium parvum infection by mice with ovalbumin-specific T cells.
Infect. Immun.
68:2663-2670[Abstract/Free Full Text].
|
| 24.
|
Marcial, M. A., and J. L. Madura.
1986.
Cryptosporidium: cellular localization, structural analysis of absorptive cell-parasite membrane-membrane interactions in guinea pigs, and suggestion of protozoan transport by M cells.
Gastroenterology
90:583-594[Medline].
|
| 25.
|
Marovich, M. A.,
C. D. Dowell,
E. K. Thomas, and T. B. Nutman.
2000.
IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand dependent process.
J. Immunol.
164:5858-5863[Abstract/Free Full Text].
|
| 26.
|
McDonald, V., and G. J. Bancroft.
1994.
Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice.
Parasite Immunol.
16:315-320[Medline].
|
| 27.
|
Pasquali, P.,
R. Fayer,
S. Almeria,
J. Trout,
G. A. Polidori, and L. C. Gasbarre.
1997.
Lymphocyte dynamic patterns in cattle during a primary infection with Cryptosporidium parvum.
J. Parasitol.
83:247-250[CrossRef][Medline].
|
| 28.
|
Perryman, L. E.,
P. H. Mason, and C. E. Chrisp.
1994.
Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice.
Infect. Immun.
62:1474-1477[Abstract/Free Full Text].
|
| 29.
|
Soong, L.,
J. C. Xu,
I. S. Grewal,
P. Kima,
J. Sun,
B. J. Longley,
N. H. Ruddle,
D. McMahon-Pratt, and R. A. Flavell.
1996.
Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.
Immunity
4:263-273[CrossRef][Medline].
|
| 30.
|
Stephens, J.,
M. Cosyns,
M. Jones, and A. Hayward.
1999.
Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice.
Hepatology
30:27-35[CrossRef][Medline].
|
| 31.
|
Subauste, C. S.,
M. Wessendarp,
R. U. Sorensen, and L. E. Leiva.
1999.
CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
J. Immunol.
162:6690-6700[Abstract/Free Full Text].
|
| 32.
|
Theodos, C. M.,
K. L. Sullivan,
J. K. Griffiths, and S. Tzipori.
1997.
Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection.
Infect. Immun.
65:4761-4769[Abstract].
|
| 33.
|
Urban, J. F.,
R. Fayer,
S. J. Chen,
W. C. Gause,
M. K. Gately, and F. D. Finkelman.
1996.
IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
J. Immunol.
156:263-268[Abstract].
|
| 34.
|
Villegas, E. N.,
U. Wille,
L. Craig,
P. S. Linsley,
D. M. Rennick,
R. Peach, and C. A. Hunter.
2000.
Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
Infect. Immun.
68:2837-2844[Abstract/Free Full Text].
|
| 35.
|
Wiley, J. A., and A. G. Harmsen.
1995.
CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.
J. Immunol.
155:3525-3529[Abstract].
|
| 36.
|
You, X., and J. R. Mead.
1998.
Characterization of experimental Cryptosporidium parvum infection in IFN-gamma knockout mice.
Parasitology
117:525-531.
|
Infection and Immunity, March 2001, p. 1630-1634, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1630-1634.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Takeuchi, D., Jones, V. C., Kobayashi, M., Suzuki, F.
(2008). Cooperative Role of Macrophages and Neutrophils in Host Antiprotozoan Resistance in Mice Acutely Infected with Cryptosporidium parvum. Infect. Immun.
76: 3657-3663
[Abstract]
[Full Text]
-
Mancassola, R., Lacroix-Lamande, S., Barrier, M., Naciri, M., Salmon, H., Laurent, F.
(2004). Increased Susceptibility of {beta}7-Integrin-Deficient Neonatal Mice in the Early Stage of Cryptosporidium parvum Infection. Infect. Immun.
72: 3634-3637
[Abstract]
[Full Text]
-
Morales, M. A. G., Mele, R., Ludovisi, A., Bruschi, F., Tosini, F., Pozio, E.
(2004). Cryptosporidium parvum-Specific CD4 Th1 Cells from Sensitized Donors Responding to Both Fractionated and Recombinant Antigenic Proteins. Infect. Immun.
72: 1306-1310
[Abstract]
[Full Text]
-
Ponnuraj, E. M., Hayward, A. R.
(2001). Intact Intestinal mRNAs and Intestinal Epithelial Cell Esterase, But Not Cryptosporidium parvum, Reach Mesenteric Lymph Nodes of Infected Mice. J. Immunol.
167: 5321-5328
[Abstract]
[Full Text]